FEDERATED HERMES, INC. - LOXO ONCOLOGY INC ownership

LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of LOXO ONCOLOGY INC
ValueSharesWeighting
Q4 2018$11,569,000
+3.9%
82,591
+26.8%
0.03%
+23.1%
Q3 2018$11,131,000
+1.5%
65,158
+3.1%
0.03%
-18.8%
Q2 2018$10,968,000
+206.4%
63,223
+103.7%
0.03%
+220.0%
Q1 2018$3,580,000
+13.0%
31,031
-9.7%
0.01%
+11.1%
Q3 2017$3,167,000
+6.0%
34,377
-7.7%
0.01%0.0%
Q2 2017$2,988,000
+42585.7%
37,258
+21561.6%
0.01%
Q1 2017$7,0001720.00%
Other shareholders
LOXO ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Aisling Capital LLC 3,438,920$289,488,00057.19%
DAFNA Capital Management LLC 296,000$24,917,00013.42%
Casdin Capital, LLC 360,000$30,305,0007.38%
Opaleye Management Inc. 176,300$14,841,0004.75%
DRIEHAUS CAPITAL MANAGEMENT LLC 574,495$48,361,0001.84%
SECTORAL ASSET MANAGEMENT INC 152,185$12,811,0001.60%
AWM Investment Company, Inc. 85,000$7,155,0001.39%
Eventide Asset Management 285,000$23,991,0001.25%
Rock Springs Capital Management LP 310,000$26,096,0001.18%
Crawford Lake Capital Management, LLC 53,420$4,497,0001.06%
View complete list of LOXO ONCOLOGY INC shareholders